Atlas, Third Rock launch new Cambridge biotech with $49M round

Atlas Venture and Third Rock Ventures have teamed up with a former GlaxoSmithKline executive to launch a new Cambridge biotech focused on improving bone marrow transplants, unveiling a $48.5 million round of financing on Wednesday. The 20-person company, Magenta Therapeutics, will be led by Jason Gardner, the former head of GSK’s research and development satellite facility in Boston. The firm is currently working out of lab space at the Forsyth Institute in Kendall Square, but plans to migrate…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news